Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine
- 30 June 1995
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 34 (6) , 665-668
- https://doi.org/10.1016/0028-3908(95)00032-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorPublished by Wiley ,2001
- Formation and inactivation of endogenous cannabinoid anandamide in central neuronsNature, 1994
- Anandamide, a Brain Endogenous Compound, Interacts Specifically with Cannabinoid Receptors and Inhibits Adenylate CyclaseJournal of Neurochemistry, 1993
- Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituentEuropean Journal of Pharmacology, 1993
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistryNeuroscience, 1992
- Anatomy of CNS opioid receptorsTrends in Neurosciences, 1988
- Interactions between cannabidiol and Δ9-THC during abstinence in morphine-dependent ratsLife Sciences, 1975
- Morphine-Dependent Rats: Blockade of Precipitated Abstinence by TetrahydrocannabinolScience, 1975
- 1-Δ 9 -Tetrahydrocannabinol: Neurochemical and Behavioral Effects in the MouseScience, 1969